至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

MALT1 promotes melanoma progression through JNK/c-Jun signaling.

Oncogenesis.. 2017-07; 
Wang Y, Zhang G, Jin J, Degan S, Tameze Y, Zhang JY.
Products/Services Used Details Operation
Catalog Products ... of the MALT1 inhibitor MI-2 (Selleckchem, Houston, TX, USA) or TRAIL. (Genscript, Piscataway, NJ, USA). ... (#28590), β1-Integrin (#9699) (Cell signaling Technology, Danvers, MA,. USA); c-Jun (Ab-243) (GenScript); RelA/p65 (SC109), IκBα (SC847), MKK7. ... Get A Quote

摘要

Mucosa-associated lymphoma antigen 1 (MALT1) is a lymphoma oncogene that regulates signal transduction as a paracaspase and an adaptor protein. Yet, the role of MALT1 in other solid cancers such as melanoma is not well-understood. Here, we demonstrate that MALT1 is overexpressed in malignant melanoma cells, and predicts a poor disease-free survival. MALT1 inhibition via shRNA-mediated gene silencing or pharmacologically with MI-2 compound markedly reduced cell growth and migration of A2058 and A375 melanoma cell lines in vitro. Subcutaneous tumor growth analysis revealed that MALT1 gene silencing significantly reduced tumor growth and metastasis to the lung. Consistently, the subcutaneous tumors with MALT1 loss... More

关键词